Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥8 | CN¥2 | CN¥2 | CN¥2 |
| - Cash | CN¥1 | CN¥1 | CN¥0 | CN¥0 |
| + Debt | CN¥1 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥8 | CN¥2 | CN¥2 | CN¥2 |
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Gross Profit | CN¥1 | CN¥1 | CN¥1 | CN¥0 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| EBITDA | CN¥0 | CN¥0 | CN¥1 | CN¥0 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| % Growth | -26.9% | -22.5% | 69% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |